ArticlePediatric research2026

Intravitreal Bevacizumab nanoparticles ameliorates retinal vasculopathy in an in vivo mouse model of retinopathy of prematurity.

Suganesh Raghunathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.